EV/IC - Hebei Changshan Biochemical Pharmaceutical Co Ltd (SZSE:300255) - Alpha Spread

Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255

Watchlist Manager
Hebei Changshan Biochemical Pharmaceutical Co Ltd Logo
Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255
Watchlist
Price: 10.31 CNY -1.34% Market Closed
Market Cap: 9.3B CNY
Have any thoughts about
Hebei Changshan Biochemical Pharmaceutical Co Ltd?
Write Note

EV/IC
Enterprise Value to IC

2.6
Current
1.6
Median
1.9
Industry
Higher than median
Higher than industry value

Enterprise Value to Invested Capital (EV/IC) ratio is a valuation multiple that measures the dollars in Enterprise Value for each dollar of capital invested by shareholders and lenders.

EV/IC
2.6
=
Enterprise Value
10.7B CNY
/
Invested Capital
4.1B CNY
All Countries
Close

EV/IC Forward Multiples

Forward EV/IC multiple is a version of the EV/IC ratio that uses forecasted invested capital for the EV/IC calculation. 1-Year, 2-Years, and 3-Years forwards use invested capital forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/IC
N/A
2-Years Forward
EV/IC
N/A
3-Years Forward
EV/IC
N/A

See Also

Discover More